Regulatory Science Framework
Advancement of Regulatory Science
pressing regulatory challenges
missing methods
advancement of methods
productâ€™s specific regulatory challenges
design methods
experimental methods
biomaterials
medical devices
borderline products
best-fitting methods
risk-benefit assessment of medical products
Regulation Authorities
tiered decision tree
missing data
technology development
assays
product-specific Decision Support System
efficient way
time efficient strategy
quality management system
physiological distribution of nanomedicines
priorities
industry
Europe
industrial R
necessary measurements
D practice of stage gating
possible standardisation
end-users
wide community of stakeholders
patients
nanosimilars
Consortium
cost
latest scientific knowledge
approach
functionalities
regulators
heart
relevance